DAFNA Capital Management as of June 30, 2015
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
AtriCure (ATRC) | 11.4 | $14M | 549k | 24.64 | |
Abbvie (ABBV) | 6.6 | $7.8M | 117k | 67.19 | |
NxStage Medical | 4.4 | $5.2M | 367k | 14.28 | |
Achillion Pharmaceuticals | 3.6 | $4.3M | 480k | 8.86 | |
Rigel Pharmaceuticals | 3.0 | $3.6M | 1.1M | 3.21 | |
Zs Pharma | 3.0 | $3.5M | 67k | 52.38 | |
BioCryst Pharmaceuticals (BCRX) | 2.8 | $3.3M | 222k | 14.93 | |
Insulet Corporation (PODD) | 2.8 | $3.3M | 106k | 30.99 | |
XenoPort | 2.8 | $3.3M | 531k | 6.13 | |
Discovery Laboratories | 2.8 | $3.3M | 4.8M | 0.68 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 2.7 | $3.2M | 4.0M | 0.80 | |
Aerie Pharmaceuticals | 2.3 | $2.8M | 157k | 17.65 | |
Derma Sciences | 2.3 | $2.7M | 374k | 7.16 | |
Synergy Pharmaceuticals | 2.2 | $2.6M | 318k | 8.30 | |
Essa Pharma | 2.2 | $2.6M | 231k | 11.36 | |
Otonomy | 2.2 | $2.6M | 112k | 22.99 | |
Applied Genetic Technol Corp C | 2.0 | $2.4M | 157k | 15.34 | |
Protalix BioTherapeutics | 2.0 | $2.4M | 1.2M | 1.95 | |
Insulet Corp note 2.000% 6/1 | 2.0 | $2.3M | 2.4M | 0.97 | |
Biotelemetry | 1.9 | $2.2M | 236k | 9.43 | |
Clovis Oncology | 1.7 | $2.0M | 23k | 87.87 | |
Stereotaxis (STXS) | 1.7 | $2.0M | 1.4M | 1.44 | |
Cynapsus Therapeutics | 1.6 | $1.9M | 95k | 20.41 | |
Masimo Corporation (MASI) | 1.5 | $1.8M | 46k | 38.73 | |
Neothetics, Inc. Cmn | 1.4 | $1.7M | 184k | 9.00 | |
Ascendis Pharma A S (ASND) | 1.4 | $1.7M | 94k | 17.68 | |
Celyad Sa | 1.3 | $1.6M | 30k | 52.03 | |
Cara Therapeutics (CARA) | 1.3 | $1.5M | 127k | 12.15 | |
Zogenix | 1.2 | $1.4M | 854k | 1.68 | |
Scynexis | 1.2 | $1.4M | 161k | 8.79 | |
Targacept | 1.1 | $1.3M | 464k | 2.79 | |
Novadaq Technologies | 1.0 | $1.2M | 102k | 12.11 | |
Dicerna Pharmaceuticals | 1.0 | $1.2M | 87k | 13.95 | |
Cytrx | 0.9 | $1.1M | 301k | 3.72 | |
Uniqure Nv (QURE) | 0.9 | $1.1M | 40k | 27.00 | |
Bluebird Bio (BLUE) | 0.8 | $1.0M | 6.0k | 168.33 | |
Dermira | 0.8 | $996k | 57k | 17.55 | |
Syneron Medical Ltd ord | 0.8 | $966k | 91k | 10.62 | |
Nuvasive Inc. conv | 0.8 | $965k | 760k | 1.27 | |
Caredx (CDNA) | 0.8 | $947k | 146k | 6.50 | |
Johnson & Johnson (JNJ) | 0.8 | $916k | 9.4k | 97.45 | |
Spectranetics Corporation | 0.8 | $916k | 40k | 23.01 | |
Arena Pharmaceuticals | 0.7 | $877k | 189k | 4.64 | |
Cardica | 0.6 | $743k | 1.5M | 0.50 | |
Lipocine | 0.6 | $729k | 85k | 8.58 | |
Exactech | 0.6 | $659k | 32k | 20.83 | |
Arca Biopharma | 0.6 | $653k | 568k | 1.15 | |
Encision | 0.5 | $584k | 1.1M | 0.55 | |
Cogentix Medical | 0.5 | $572k | 353k | 1.62 | |
RTI Biologics | 0.5 | $555k | 86k | 6.46 | |
Cynapsus Therapeutics | 0.5 | $559k | 34k | 16.44 | |
Intercept Pharmaceuticals In | 0.4 | $483k | 2.0k | 241.50 | |
Lumenis Ltd shs cl b | 0.4 | $426k | 31k | 13.71 | |
Tandem Diabetes Care | 0.3 | $390k | 36k | 10.84 | |
Affimed Therapeutics B V | 0.3 | $390k | 29k | 13.47 | |
Check Cap | 0.3 | $385k | 110k | 3.50 | |
Ironwood Pharma note 2.25% 15-jun-2022 144a sr unsecured conv | 0.3 | $396k | 400k | 0.99 | |
Aptose Biosciences | 0.3 | $359k | 70k | 5.10 | |
Pieris Pharmaceuticals | 0.3 | $344k | 125k | 2.75 | |
Venaxis | 0.2 | $296k | 658k | 0.45 | |
Marinus Pharmaceuticals | 0.2 | $259k | 22k | 11.60 | |
Actinium Pharmaceuticals | 0.2 | $239k | 90k | 2.66 | |
Loxo Oncology | 0.2 | $221k | 12k | 18.05 | |
Nivalis Therapeutics | 0.2 | $227k | 15k | 15.13 | |
Cel-sci | 0.2 | $209k | 317k | 0.66 | |
Genvec | 0.2 | $204k | 100k | 2.04 | |
Biotie Therapies Corp. ads | 0.2 | $200k | 10k | 20.00 | |
Caladrius Biosciences | 0.1 | $166k | 89k | 1.87 | |
Oncothyreon | 0.1 | $135k | 36k | 3.73 | |
Chembio Diagnostics | 0.1 | $129k | 26k | 4.91 | |
CAS Medical Systems | 0.1 | $113k | 89k | 1.28 | |
Transition Therapeutics | 0.1 | $124k | 59k | 2.09 | |
Corbus Pharmaceuticals Hldgs | 0.1 | $113k | 37k | 3.09 | |
Antares Pharma | 0.1 | $94k | 45k | 2.09 | |
Check Cap Ltd w exp 02/28/202 | 0.1 | $96k | 55k | 1.75 |